Table 2.
Effects of AFG on body weight of DM mice (, n = 12).
Group | Dosage (mg/kg) | Before administration | After administration | |||
---|---|---|---|---|---|---|
4 weeks | Weight gain (g) | Liver index (mg/g) | Spleen index (mg/g) | |||
Normal | — | 38.75 ± 3.29 | 40.35 ± 2.92 | 1.60 | 47.10 ± 2.87 | 3.43 ± 0.90 |
STZ | — | 38.94 ± 4.51 | 35.68 ± 2.49## | −3.26 | 63.90 ± 4.78## | 5.37 ± 0.73# |
AFG | 20 | 38.91 ± 2.77 | 38.94 ± 2.86 | 0.03 | 50.21 ± 4.35∗∗ | 4.64 ± 0.84 |
40 | 38.09 ± 3.63 | 38.31 ± 3.94 | 0.22 | 48.93 ± 3.94∗∗ | 4.41 ± 0.65 | |
80 | 38.81 ± 3.49 | 39.51 ± 3.18∗ | 0.70 | 50.74 ± 5.38∗∗ | 3.66 ± 0.57∗ |
# P < 0.05, ##P < 0.01, as equated with the normal group; ∗P < 0.05, ∗∗P < 0.01, as equated with the STZ group. The same as follows.